secwatch / observer
8-K filed January 12, 2026, 6:59 PM ET ticker BCAB CIK 0001826892
other material confidence high sentiment negative materiality 0.80

BioAtla issues super-voting share to CEO; reverse stock split vote fails, adjourned to Jan 26

BioAtla, Inc.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

BioAtla, Inc. issued one (1) share of preferred stock to Jay M. Short, Ph.D. for $0.01.

Security
preferred stock
Shares
one (1) share
Purchaser
Jay M. Short, Ph.D.
Consideration
$0.01
Exact text from the filing
to Jay M. Short, Ph.D., the Company’s Chairman, Chief Executive Officer and co-founder, for the purchase price of $0.01.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BioAtla, Inc.: Filed Certificate of Designation for Series A Junior Preferred Stock (Super-Voting Share) establishing its voting, dividend, liquidation, redemption, and transfer terms (effective 2026-01-09).

Change
charter amendment
Effective
2026-01-09
Exact text from the filing
On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.
View on SEC.gov

Browse all equity issuances →

BioAtla, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-010458
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.